account_balance
Investment manager · 13F filer · SEC CIK 1232621
Tang Capital Management LLC
Reported value$2.2Bas of Jun 30, 2026
Positions41 5 new, 15 sold out
Top 10 weight62.7%AUPH alone is 10%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
AUPHAurinia Pharmaceuticals Inc
10.1%Added +7%
SYRESpyre Therapeutics Inc
7.6%
MIRMMirum Pharmaceuticals Inc
6.6%
KNSAKiniksa Pharmaceuticals Intl
6.6%
CELCCelcuity Inc
6.2%Added +25%
CORTCorcept Therapeutics Inc
5.9%
PTCTPTC Therapeutics Inc
5.6%
LKFTLakefront Biotherapeutics NV
5.2%
CAPRCapricor Therapeutics Inc
4.5%Added +21%
TARSTarsus Pharmaceuticals Inc
4.5%Added +32%
SPYState STR SPDR S&P 500 ETF T
4.2%Trimmed −27%
ANABAnaptysbio Inc
4.1%
AUPHAurinia Pharmaceuticals Inc
10.1%Added +7%
SYRE7.6%MIRM6.6%KNSAKiniksa Pharmaceuticals Intl
6.6%
CELCCelcuity Inc
6.2%Added +25%
CORTCorcept Therapeutics Inc
5.9%
PTCT5.6%LKFT5.2%CAPR4.5%TARS4.5%SPY4.2%ANAB4.1%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
AUPH Aurinia Pharmaceuticals Inc 10.1% Added +7%SYRE Spyre Therapeutics Inc 7.6% HeldMIRM Mirum Pharmaceuticals Inc 6.6% HeldKNSA Kiniksa Pharmaceuticals Intl 6.6% HeldCELC Celcuity Inc 6.2% Added +25%CORT Corcept Therapeutics Inc 5.9% HeldPTCT PTC Therapeutics Inc 5.6% HeldLKFT Lakefront Biotherapeutics NV 5.2% HeldCAPR Capricor Therapeutics Inc 4.5% Added +21%TARS Tarsus Pharmaceuticals Inc 4.5% Added +32%SPY State STR SPDR S&P 500 ETF T 4.2% Trimmed −27%ANAB Anaptysbio Inc 4.1% Held
What changed